New diarylsulfonamide inhibitors of Leishmania infantum amastigotes
New drugs against visceral leishmaniasis with mechanisms of action differing from existing treatments and with adequate cost, stability, and properties are urgently needed. No antitubulin drug is currently in the clinic against Leishmania infantum, the causative agent of visceral leishmaniasis in th...
Main Authors: | Myriam González, Pedro José Alcolea, Raquel Álvarez, Manuel Medarde, Vicente Larraga, Rafael Peláez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-08-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211320721000099 |
Similar Items
-
Effect of thiadiazine derivatives on intracellular amastigotes of Leishmania amazonensis
by: Lianet Monzote Fidalgo, et al.
Published: (2004-05-01) -
Role of Leishmania (Leishmania) amazonensis amastigote glycosphingolipids in macrophage infectivity
by: A.K. Tanaka, et al.
Published: (2007-06-01) -
Analysis and chromosomal mapping of Leishmania (Leishmania) amazonensis amastigote expressed sequence tags
by: Luciana Girotto Gentil, et al.
Published: (2007-09-01) -
Obtención y mantenimiento en cultivo de amastigotes axénicos de Leishmania peruviana y Leishmania brazilensis
by: Jesús Rojas Jaimes, et al.
Published: (2020-09-01) -
Development of monoclonal antibodies against axenic amastigotes of Leishmania infantum strain in Iran: Implication for diagnosis of Kala-azar
by: Ezzat nourizadeh, et al.
Published: (2018-04-01)